← Back to Search

Behavioural Intervention

ADAPT+ for Childhood Obesity (ADAPT+ Trial)

N/A
Waitlist Available
Led By Marilyn Stern, PhD
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, at study initiation, two months, three months, and five months
Awards & highlights

ADAPT+ Trial Summary

This trial is testing a new obesity intervention that combines a standard family-based behavioral approach with a mindfulness approach focusing on stress reduction.

Eligible Conditions
  • Childhood Obesity

ADAPT+ Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, at study initiation, two months, three months, and five months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, at study initiation, two months, three months, and five months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability
Feasibility - Accrual Rates
Feasibility - Number of Sessions Completed
+1 more
Secondary outcome measures
Child BMI z score
Child Food and PA Questionnaire
Child Step count
+7 more

ADAPT+ Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Feasibility and acceptability of ADAPT+Experimental Treatment1 Intervention
ADAPT+ is a family-based obesity intervention for high-risk Latino youth and their parents living in rural communities that incorporates culture-specific components and mindfulness-based approaches to promote adaptive health behaviors in a high-risk and underserved population.
Group II: Enhanced Usual Care (EUC)Active Control1 Intervention
Enhanced Usual Care (EUC) provides publicly available material in both English and Spanish on the role of diet and exercise in pediatric obesity in a one-time information session.

Find a Location

Who is running the clinical trial?

University of South FloridaLead Sponsor
407 Previous Clinical Trials
186,701 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
831 Previous Clinical Trials
668,825 Total Patients Enrolled
Marilyn Stern, PhDPrincipal InvestigatorUniversity of South Florida
2 Previous Clinical Trials
626 Total Patients Enrolled

Media Library

ADAPT+ (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04800432 — N/A
Childhood Obesity Research Study Groups: Feasibility and acceptability of ADAPT+, Enhanced Usual Care (EUC)
Childhood Obesity Clinical Trial 2023: ADAPT+ Highlights & Side Effects. Trial Name: NCT04800432 — N/A
ADAPT+ (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04800432 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible to participate in this clinical examination?

"This trial is seeking 108 children between the ages of 8 and 12 who are classified as obese according to BMI percentile. To be eligible, they must have a parent that meets certain criteria: 18 years or older, responsible for meal preparation, able to read Spanish at least up to fourth grade level (basic instructions), and physically capable of performing simple exercises."

Answered by AI

What primary objectives is this clinical trial seeking to achieve?

"This 8-week clinical trial is designed to evaluate the feasibility of achieving physical activity goals. Alongside this primary outcome, secondary outcomes such as dietary habits (assessed through a 13-item self-report survey), child BMI z score (measured by study staff) and perceived stress scale (14 item self-report scale completed by parents) will be monitored."

Answered by AI

Is the enrollment period for this research project still active?

"According to clinicaltrials.gov, the enrollment for this trial has already closed; its initial posting was on March 6th 2021 and final edit occurred November 2nd 2022. Despite that, 1,007 other trials are actively recruiting patients at this time."

Answered by AI

Does this experiment encompass elderly individuals aged 85 or older?

"As per the prerequisites for joining this clinical trial, participants must be between 8 and 12 years of age."

Answered by AI
Recent research and studies
~26 spots leftby Apr 2025